Business
Notice of interim results
Notice of interim results.
About this update from Shield Therapeutics Plc
[{"type":"text","content":"\n\nShield Therapeutics plc\n(\"Shield\" or the \"Company\" or the \"Group\")\n \nNotice of interim results\n \nLondon, UK, 14 August 2024: Shield Therapeutics plc (LSE: STX), a commercial stage pharmaceutical company that delivers Accrufer®/Feraccru® (ferric maltol), an innovative and differentiated specialty pharmaceutical product, to address a significant unmet need for patients suffering from iron deficiency (with or without anaemia), will announce its interim results for the six months ended 30 June 2024 on Wednesday 4 September 2024.\n \nInvestor presentation\nInterim CEO, Anders Lundstrom, and CFO, Santosh Shanbhag, will be hosting a live online presentation relating to the interim results via the Investor Meet Company platform at 4.30pm (BST) on Wednesday 4 September 2024.\n \nThe presentation is open to all existing and potential investors. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 09.00am (BST) the day before the meeting or at any time during the live presentation.\n \nInvestors can sign up to Investor Meet Company for free and add to meet Shield Therapeutics plc via:\n \nhttps://www.investormeetcompany.com/shield-therapeutics-plc/register-investor\n \nInvestors who already follow Shield Therapeutics plc on the Investor Meet Company platform will automatically be invited.\n \nFor further information please contact:\n \n\n\n\n\nShield Therapeutics plc\n\n\nwww.shieldtherapeutics.com\n\n\n\n\nAnders Lundstrom, Interim CEO\n\n\n+44 (0) 191 511 8500\n\n\n\n\nSantosh Shanbhag, CFO\n\n\n\n\n\n\n\n \nNominated Adviser and Joint Broker\n\n\n\n\n\n\n\nPeel Hunt LLP\n\n\n\n\n\n\n\nJames Steel/Patrick Birkholm\n\n\n+44 (0)20 7418 8900\n\n\n\n\n \nJoint Broker\nCavendish Ltd Geoff Nash / Rory Sale / Nigel Birks / Harriet Ward \n\n\n \n \n \n+44 (0)20 7220 0500\n\n\n\n\n\n\n\n\n\n\n\n\nFinancial PR & IR Advisor\n\n\n\n\n\n\n\nWalbrook PR\n\n\n\n\n\n\n\nCharlotte Edgar / Alice Woodings\n\n\n+44 (0)20 7933 8780 or [email protected]\n\n\n\n\n\n\n\n\n\n\n\n\nAbout Iron Deficiency and Accrufer®/Feraccru®\nClinically low iron levels (aka iron deficiency, ID) can cause serious health problems for adults of all ages, across multiple therapeutic areas. Together, ID and ID wi...